NO20005498D0 - Form of 1- (6-chloro naphth-2-ysulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size - Google Patents

Form of 1- (6-chloro naphth-2-ysulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size

Info

Publication number
NO20005498D0
NO20005498D0 NO20005498A NO20005498A NO20005498D0 NO 20005498 D0 NO20005498 D0 NO 20005498D0 NO 20005498 A NO20005498 A NO 20005498A NO 20005498 A NO20005498 A NO 20005498A NO 20005498 D0 NO20005498 D0 NO 20005498D0
Authority
NO
Norway
Prior art keywords
ysulfonyl
naphth
piperazine
pyridyl
benzoyl
Prior art date
Application number
NO20005498A
Other languages
Norwegian (no)
Other versions
NO20005498L (en
Inventor
Marianne Ashford
Roger James
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20005498L publication Critical patent/NO20005498L/en
Publication of NO20005498D0 publication Critical patent/NO20005498D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20005498A 1998-05-02 2000-11-01 Form of 1- (6-chloro naphth-2-ysulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size NO20005498D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809350.3A GB9809350D0 (en) 1998-05-02 1998-05-02 Novel salt
PCT/GB1999/001316 WO1999057112A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine

Publications (2)

Publication Number Publication Date
NO20005498L NO20005498L (en) 2000-11-01
NO20005498D0 true NO20005498D0 (en) 2000-11-01

Family

ID=10831311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005498A NO20005498D0 (en) 1998-05-02 2000-11-01 Form of 1- (6-chloro naphth-2-ysulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size

Country Status (16)

Country Link
EP (1) EP1084118A1 (en)
JP (1) JP2002513789A (en)
KR (1) KR20010043216A (en)
CN (1) CN1308629A (en)
AU (1) AU3719699A (en)
BR (1) BR9910176A (en)
CA (1) CA2331041A1 (en)
EE (1) EE200000638A (en)
GB (1) GB9809350D0 (en)
HU (1) HUP0102394A3 (en)
IL (1) IL139405A0 (en)
NO (1) NO20005498D0 (en)
PL (1) PL343705A1 (en)
SK (1) SK16522000A3 (en)
WO (1) WO1999057112A1 (en)
ZA (1) ZA200006036B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1031563T3 (en) 1997-09-30 2006-05-08 Daiichi Seiyaku Co sulphonyl derivatives
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
CN100513398C (en) 2002-12-03 2009-07-15 Axys药物公司 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56197C2 (en) * 1996-11-08 2003-05-15 Зенека Лімітед Heterocyclic derivatives
US6359134B1 (en) * 1997-05-30 2002-03-19 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
DK1031563T3 (en) * 1997-09-30 2006-05-08 Daiichi Seiyaku Co sulphonyl derivatives

Also Published As

Publication number Publication date
HUP0102394A2 (en) 2001-12-28
EP1084118A1 (en) 2001-03-21
BR9910176A (en) 2001-01-09
AU3719699A (en) 1999-11-23
SK16522000A3 (en) 2001-05-10
GB9809350D0 (en) 1998-07-01
HUP0102394A3 (en) 2003-01-28
CN1308629A (en) 2001-08-15
NO20005498L (en) 2000-11-01
JP2002513789A (en) 2002-05-14
EE200000638A (en) 2002-04-15
CA2331041A1 (en) 1999-11-11
KR20010043216A (en) 2001-05-25
ZA200006036B (en) 2002-01-25
WO1999057112A1 (en) 1999-11-11
PL343705A1 (en) 2001-08-27
IL139405A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
ES8405786A1 (en) 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
NO924764D0 (en) 4-PYRIMIDINYL AND PYRIDINYL DERIVATIVES OF INDOL-3-YL ALKYL PIPERAZINE
DE60030338D1 (en) Use of 1- 4- (5-cyanoindol-3-yl) butyl -4- (2-carbamoylbenzofuran-5-yl) piperazine and its physiologically acceptable salts
DE60125980D1 (en) P38 KINASE INHIBITORS OF THE PIPERIDINE / PIPERAZINE TYPE
FI19991729A (en) Enantiomers of 1 - ((4-chlorophenyl) phenylmethyl) -4 - ((methylphenyl) sulfonyl) piperazine
CH1175401H1 (en) Piperazine derivatives useful as CCR5 antagonists
DE60136736D1 (en) Pyrimidine derivatives and their use in the treatment of atherosclerosis
ATE343565T1 (en) PHENYL AND PYRIDINYL DERIVATIVES USABLE AS NEUROKININ-1 ANTAGONISTS
NO20000115D0 (en) Gastro-kinetic monocyclic benzamides of 3- or 4- substituted 4- (aminomethyl) -piperidine derivatives
ATE474828T1 (en) ARYL SUBSTITUTED PYRIDINES, PYRIMIDINES, PYRAZINE AND TRIAZINE AND THEIR USE
NO984380D0 (en) New piperazine and piperidine compounds
DK1131308T3 (en) Piperazine and piperidine derivatives
EE200100498A (en) 1,4-substituted piperazine, 1,4-substituted piperidine and 1-substituted 4-alkylidenylpiperidine compounds and their therapeutic uses
DE69106388T2 (en) ANTIPSYCHOTIC 4- (1,2-BENZISOAZOLYL) PIPERIDINE DERIVATIVES.
ES8402832A1 (en) 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
NO20005498D0 (en) Form of 1- (6-chloro naphth-2-ysulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size
GB9022820D0 (en) Piperazine derivatives
ATE553097T1 (en) PIPERIDINE AND PIPERAZINE SUBSTITUTED N-HYDROXYFORMAMIDES FOR USE AS METALLOPROTEINASE INHIBITORS
ATE203237T1 (en) PSEUDOPOLYMORPHIC FORMS OF 2-(2-(4-(BIS(4- FLUOROPHENYL)METHYL)-1-PIPERAZINYL)ETHOXY)ACETIC ACID DIHYDROCHLORIDE
FI923723A (en) 4- (4- (4 - (- HYDROXIPHENYL) -1-PIPERAZINYL) PHENYL) -5-METHYL-3H-1,2,4-TRIAZOL-3-ON DERIVATIVES
IL157061A (en) Process and intermediates for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl)piperazin -1-yl)-methanone and salts thereof
HK1062683A1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(E)-=-methyloxime and its salts.
AU2001225369A1 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application